Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Humana Inc. (NYSE:HUM - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 188,793 shares of the insurance provider's stock after acquiring an additional 16,089 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.16% of Humana worth $49,552,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares in the last quarter. Pzena Investment Management LLC lifted its stake in Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares in the last quarter. Boston Partners boosted its holdings in Humana by 435.8% during the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after acquiring an additional 893,637 shares during the period. Retirement Systems of Alabama grew its position in Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new stake in Humana during the third quarter worth about $50,102,000. Hedge funds and other institutional investors own 92.38% of the company's stock.
Humana Stock Performance
HUM traded down $0.36 on Wednesday, hitting $264.39. 269,608 shares of the company traded hands, compared to its average volume of 1,551,096. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The company has a 50 day moving average of $269.37 and a 200-day moving average of $272.67. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $31.91 billion, a PE ratio of 26.57, a PEG ratio of 2.05 and a beta of 0.57.
Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.
Humana Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio (DPR) is 35.58%.
Analyst Ratings Changes
HUM has been the subject of a number of research reports. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Barclays boosted their price target on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 13th. Truist Financial increased their price objective on Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research note on Monday, January 6th. Piper Sandler upped their price target on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Eighteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Humana has an average rating of "Hold" and a consensus price target of $285.68.
Check Out Our Latest Stock Report on Humana
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
